No directly tagged education is live for Dermatology yet. Use the specialty context below plus relevant cross-specialty education while the dedicated hub is expanded.
Use the specialty context and cross-specialty learning below while dedicated modules, podcasts and webinars are added.
Long-term safety and efficacy study of amlitelimab for moderate-to-severe atopic dermatitis, including drug withdrawal to assess treatment durability.
Study comparing how the body processes nusinersen delivered via an implantable device versus lumbar puncture in spinal muscular atrophy patients.
Multi-drug trial testing new treatments for moderate to severe eczema in adults.
Concizumab daily injections tested in haemophilia A/B patients to prevent bleeds over 2-4 years.
Recorded webinar focused on JAK inhibitors in rheumatology and immune-mediated inflammatory disease. Reviews JAK-STAT signalling, patient selection, ORAL Surveillance safety signals, cardiovascular…
JAK inhibitors target the JAK-STAT pathway, interrupting intracellular cytokine signalling across several inflammatory diseases. ORAL Surveillance reshaped risk assessment after higher rates…